Clearmind Medicine Financials
| CMND Stock | USD 1.30 0.02 1.56% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | 1.33 |
|
|
Investors should never underestimate Clearmind Medicine's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Clearmind Medicine's cash flow, debt, and profitability to make informed and accurate decisions about investing in Clearmind Medicine Common.
Net Income |
|
Clearmind | Select Account or Indicator |
Understanding current and past Clearmind Medicine Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clearmind Medicine's financial statements are interrelated, with each one affecting the others. For example, an increase in Clearmind Medicine's assets may result in an increase in income on the income statement.
Please note, the presentation of Clearmind Medicine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clearmind Medicine's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Clearmind Medicine's management manipulating its earnings.
Clearmind Medicine Stock Summary
Clearmind Medicine competes with Cue Biopharma, Tff Pharmaceuticals, Lantern Pharma, Eliem Therapeutics, and Inhibrx. Clearmind Medicine is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 185053204 185053402 |
| Location | Canada (Federal Level) |
| Business Address | 1220 West 6th |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.clearmindmedicine.com |
| Phone | 604 260 1566 |
| Currency | USD - US Dollar |
Clearmind Medicine Key Financial Ratios
| Return On Equity | -2.68 | ||||
| EBITDA | (8.71 M) | ||||
| Net Income | (6.23 M) | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 0.87 X |
Clearmind Medicine Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 512.7K | 5.2M | 1.1M | 4.3M | 5.0M | 5.2M | |
| Net Tangible Assets | 133.8K | 319.6K | 4.6M | (1.7M) | (1.9M) | (1.8M) | |
| Retained Earnings | (539.7K) | (4.4M) | (13.8M) | (13.6M) | (12.3M) | (11.7M) | |
| Accounts Payable | 4.0K | 281.5K | 1.0M | 448.2K | 515.4K | 541.2K | |
| Cash | 329.8K | 4.6M | 175.8K | 3.9M | 4.5M | 4.7M | |
| Total Liab | 13.4K | 357.2K | 2.6M | 3.6M | 4.2M | 4.4M | |
| Total Current Assets | 333.0K | 4.9M | 593.3K | 4.2M | 4.8M | 5.1M | |
| Common Stock | 891.7K | 7.9M | 9.2M | 12.4M | 14.3M | 15.0M | |
| Other Current Liab | 6.1K | 6.7K | 1.6M | 3.2M | 3.6M | 3.8M | |
| Net Debt | (329.8K) | (4.6M) | (123.4K) | (3.9M) | (3.5M) | (3.4M) | |
| Net Receivables | 3.1K | 129.8K | 133.7K | 174.6K | 200.8K | 210.8K | |
| Net Invested Capital | 499.3K | 4.8M | (1.5M) | 983.5K | 885.1K | 785.4K | |
| Capital Stock | 891.7K | 7.9M | 9.2M | 17.1M | 19.7M | 20.7M | |
| Net Working Capital | 319.6K | 4.6M | (2.0M) | 824.8K | 742.3K | 579.6K |
Clearmind Medicine Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 329.2K | 4.3M | (4.4M) | 3.8M | 4.4M | 4.6M | |
| Net Income | (233.2K) | (3.9M) | (9.4M) | (6.2M) | (5.6M) | (5.3M) | |
| End Period Cash Flow | 329.8K | 4.6M | 175.8K | 3.9M | 4.5M | 4.7M | |
| Free Cash Flow | (274.5K) | (3.1M) | (5.1M) | (4.6M) | (4.1M) | (3.9M) | |
| Depreciation | 179.69 | 2.6K | 113.4K | 41.6K | 37.4K | 68.9K | |
| Other Non Cash Items | 28.0 | 189.7K | 836.9K | 2.1M | 2.4M | 2.5M | |
| Change To Inventory | 28.0 | 157.7K | (27.2K) | 151.5K | 174.2K | 182.9K | |
| Investments | (5.1K) | (251.2K) | (7.6K) | (26.2K) | (23.6K) | (24.8K) |
Clearmind Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clearmind Medicine's current stock value. Our valuation model uses many indicators to compare Clearmind Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clearmind Medicine competition to find correlations between indicators driving Clearmind Medicine's intrinsic value. More Info.Clearmind Medicine Common is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Clearmind Medicine's Return On Equity is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearmind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Clearmind Medicine Common Systematic Risk
Clearmind Medicine's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Clearmind Medicine volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Clearmind Medicine Common correlated with the market. If Beta is less than 0 Clearmind Medicine generally moves in the opposite direction as compared to the market. If Clearmind Medicine Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clearmind Medicine Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clearmind Medicine is generally in the same direction as the market. If Beta > 1 Clearmind Medicine moves generally in the same direction as, but more than the movement of the benchmark.
About Clearmind Medicine Financials
What exactly are Clearmind Medicine Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Clearmind Medicine's income statement, its balance sheet, and the statement of cash flows. Potential Clearmind Medicine investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Clearmind Medicine investors may use each financial statement separately, they are all related. The changes in Clearmind Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearmind Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Clearmind Medicine Thematic Clasifications
Clearmind Medicine Common is part of several thematic ideas from IT to Computers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Clearmind Medicine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Clearmind Medicine's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Clearmind Medicine growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Clearmind Medicine November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Clearmind Medicine help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clearmind Medicine Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clearmind Medicine Common based on widely used predictive technical indicators. In general, we focus on analyzing Clearmind Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clearmind Medicine's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.53 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 45.83 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.13 |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |